Healthcare Triangle Inc. (NASDAQ: HCTI) stock fell -5.13% on Monday to $0.23 against a previous-day closing price of $0.25. With 0.37 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.49 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.2520 whereas the lowest price it dropped to was $0.2201. The 52-week range on HCTI shows that it touched its highest point at $1.68 and its lowest point at $0.11 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HCTI was up-trending over the past week, with a rise of 6.01%, but this was up by 8.98% over a month. Three-month performance dropped to -28.88% while six-month performance fell -65.74%. The stock lost -85.02% in the past year, while it has gained 29.66% so far this year.
Float and Shares Shorts:
At present, 36.02 million HCTI shares are outstanding with a float of 15.08 million shares on hand for trading. On Dec 29, 2022, short shares totaled 0.16 million, which was 0.38% higher than short shares on Nov 29, 2022. In addition to Mr. Anand Kumar as the firm’s Sr. VP & Head of Cloud Solutions, Mr. Sudish Mogli serves as its Consultant.
Through their ownership of 7.92% of HCTI’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 7.91% of HCTI, in contrast to 4.62% held by mutual funds. Shares owned by individuals account for 0.01%. As the largest shareholder in HCTI with 7.40% of the stake, Armistice Capital LLC holds 3,080,439 shares worth 3,080,439. A second-largest stockholder of HCTI, Gladstone Institutional Advisory, holds 70,000 shares, controlling over 0.17% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in HCTI, holding 61,964 shares or 0.15% stake. With a 0.01% stake in HCTI, the Vanguard Extended Market Index Fu is the largest stakeholder. A total of 4,362 shares are owned by the mutual fund manager. The Vanguard Total Stock Market Index, which owns about 0.00% of HCTI stock, is the second-largest Mutual Fund holder. It holds 0 shares valued at 0.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Sep 29, 2022, HCTI reported revenue of $11.59M and operating income of -$1.43M. The EBITDA in the recently reported quarter was -$589.00k and diluted EPS was -$0.01.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HCTI since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With HCTI analysts setting a high price target of $1.50 and a low target of $1.50, the average target price over the next 12 months is $1.50. Based on these targets, HCTI could surge 552.17% to reach the target high and rise by 552.17% to reach the target low. Reaching the average price target will result in a growth of 552.17% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. HCTI will report FY 2022 earnings on 03/05/2024. Analysts have provided yearly estimates in a range of -$0.20 being high and -$0.20 being low. For HCTI, this leads to a yearly average estimate of -$0.20. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Healthcare Triangle Inc. surprised analysts by -$0.03 when it reported -$0.07 EPS against a consensus estimate of -$0.04. The surprise factor in the prior quarter was $0.04. Based on analyst estimates, the high estimate for the next quarter is -$0.04 and the low estimate is -$0.04. The average estimate for the next quarter is thus -$0.04.
Summary of Insider Activity:
Insiders traded HCTI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.